Current situation of chinese-herbs-induced renal damage and its countermeasures

Dai Xi-wen; Rao Xiang-rong; Li Shen

doi:10.1007/BF03178480

Your Location：

Home >

Browse articles >

Current situation of chinese-herbs-induced renal damage and its countermeasures

OriginalPaper | Updated：2021-08-27

- Current situation of chinese-herbs-induced renal damage and its countermeasures
- Current situation of chinese-herbs-induced renal damage and its countermeasures
- 中国结合医学杂志（英文版） 2001年7卷第3期页码：162-166
- Affiliations：
  
  Guang’anmen Hospital, China Academy of Traditional Chinese Medicine,Beijing
- Author bio：
- Funds：
- DOI：10.1007/BF03178480
  中图分类号：
- 纸质出版日期：2001，
Scan for full text
Dai, Xw., Rao, Xr. & Li, S. Current situation of chinese-herbs-induced renal damage and its countermeasures., CJIM 7, 162 (2001). https://doi.org/10.1007/BF03178480

Dai Xi-wen, Rao Xiang-rong, Li Shen. Current situation of chinese-herbs-induced renal damage and its countermeasures[J]. Chinese Journal of Integrative Medicine, 2001,7(3):162-166.
Dai, Xw., Rao, Xr. & Li, S. Current situation of chinese-herbs-induced renal damage and its countermeasures., CJIM 7, 162 (2001). https://doi.org/10.1007/BF03178480 DOI：

Dai Xi-wen, Rao Xiang-rong, Li Shen. Current situation of chinese-herbs-induced renal damage and its countermeasures[J]. Chinese Journal of Integrative Medicine, 2001,7(3):162-166. DOI： 10.1007/BF03178480.

摘要

Abstract

关键词

Renal DamageChinese HerbAristolochic AcidKaempferiFanconi Syndrome

Keywords

Renal DamageChinese HerbAristolochic AcidKaempferiFanconi Syndrome

references

Izumaotani T, Ishimura E, Tsmara K, et al. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs. Nephron 1993;65:137.

Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapid progressive interstitial renal fibrosis in young women. Lancet 1993;341:387.

Depierreux M, Damme BV, Houte KV, et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994;24:172.

Cosyns JP, Jadoul M, Squifflet JP, et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994;45:1680.

Kabanda A, Jadoul M, Lauwerys R, et al. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48: 1571.

LEE CT, WU MS, LU K, et al. Renal tubular acidosis, hypokalemic paralysis, rhabdomyolysis, and acute renal failure — a rare presentation of Chinese herbs nephropathy. Renal Failure 1999;21:227.

YANG CS, LIN CH, CHANG SH, et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000;2:313–318.

Lord GM, Tagore R, Gower P, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354(9177):481–482.

Vanherweghem JL. Misuse of herbal remedies. The case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998;4:9–13.

Wankowicz Z, Obroniecha J, Morzycka-Michalik M. Nephropathy after use of Chinese herbs: rapid progressive interstitial renal fibrosis or renal vasculitis. Pol Arch Med Wewn 1996;96(5):474–478.

Yoshimura E, Fujii M, Koide S, et al. A case of Chinese herbs nephropathy in which the progression of renal dysfunction was slowed by steroid therapy. Nippon Jinzo Gakkai SHI 2000;42(2):66–72.

Tanaka A, Shinkai S, Kasuno K, et al. Chinese herbs nephropathy in the Kansai area: a warning report. Nippon Jinzo Gakkai SHI 1997;39(4):438–440.

Reginster F, Jadoul M, Struhou VY. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephro Dial Transplant 1997;12(1):81–86.

Tanaka A, Shinkai S, Kasuno K, et al. Chinese herbs nephropathy in Japan presents adult-onset Fanconi syndrome: could different components aristolochic acids cause a different type of Chinese herbs nephropathy? Clin Nephrol 2000;53(4):301–306.

YIN G, HU WX, LI LS. Chinese herb nephropathy: experience of three cases of nephrotoxicity caused by Akebia quinata. J Nephrol Dialy Transplant 1998;8(1):10–14.

QIU Q, LIU ZH, YANG JW, et al. Experiment study of acute nephrotoxicity induced by Aristolochia manshuriensis Kom in rats. J Nephrol Dialy Transplant 1998;8(1):15–18.

Norden AG, Scheinman SJ, Descholdt-Lanchman MM, et al. Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 2000;57(1):240–249.

Nortier, Denscholdt-Lanchman, Simon. Proximal tubular injury in Chinese herbs nephropathy monitoring by neutral endopeptidase enzymuria. Kidney Int 1997;51:288–293.

John K. Nephropathy associated with the use of Aristolochia. Herbal Gram 2000;48:44–45.

HUANG KE, LI XB. Analysis of nephrotoxic Chinese herbs’ characters. New Chin Med Clin Pharmacol 1996;7(3):48–49.

GUO ZA. The Chinese herbs’ renal lesion. Chin J Integr Med 1998;18(1):54–56.

Tanaka A, Nishida R, Maeda K, et al. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of Aristolochic acid cause a different type of Chinese herb nephropathy? Nephrol 2000;53(4):301–306.

Nouwen EJ, Zhu MQ, Savin M, et al. Introduce of apoptosis in the rat kidney by aristolochic acid. Abstract of 1995 ASN Annual Meeting; USA P1002.

Stuborova M, Frei E. Aristololactam I, a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxicol Pathol 1999;51(4–5):421–427.

Nortier JL, Martinez MC, Schmeiser, et al. Urothelial carcinoma associated with the use of a Chinese herb. N Eng J Med 2000;342(23):1686–1692.

Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33(6):1011–1017.

Megyesi J, Udvarrhely N, Safirstein RL, et al. The p53-independent activation of transcription of p21 WAF1/C1P1/sdl1 after acute renal failure. Am J Physiol 1996;271:1211–1216.

Godley JP, Kopp JB, Eckhaus M, et al. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 1996;10(7):836–850.

Cosyns JP, Goebbels RM, Liberton V, et al. Organ toxicity and mechanisms: Chinese herb nephropathy-associated slimming regimen induces tumors in the forestomach but no interstitial nephropathy in rats. Arch Toxicol 1998;72:738–743.

WANG HY: Reinforce the study of the effect of tubular-interstitial lesion on the progression of glomerular diseases. Chin J Nephrol 2000;16(2):5–6.

Vanherweghem JL, Abramowicz D, Tielemens, et al. Effects of steroids on the progression of renal failure in chronic interstitial nephropathy in rats: a pilot study in Chinese herb nephropathy. Am J Kidney Dis 1996;27(2):209–215.

GAO RT, ZHENG FL, LIU YX, et al. Variation of intracellular free calcium concentration in aristolochic acid I induced apoptosis in LLC-PK1 cells and inhibition on apoptotic damage by Lacidine. J Nephrol Dialy Transplant 1998;8(1):6–9.

ZHANG WH. To compare the diuresis and poisonous effects of three kinds of Mutong. Chin J Pharmacol 1989:594–596.

CUI TG, WANG HY, SHANG MY, et al. Influence of caulis aristolochiae manchuriensis decoction on renal function and interstitial structure in rats at statuary dose according to pharmacopoeia. Chin J Nephrol 2000;16(2):106–109.

FULL TEXT LINK

More>

浏览量

390

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

A re-understanding on the safety matters of Chinese herbal medicine

Application of metabolomics technology in the research of Chinese medicine

A case of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome treated with chinese herbs

Clinical characteristics of prostate cancer in advanced stage and its treatment by Chinese and Western medicine

Experiences in treating diabetic peripheral neuropathy with traditional Chinese medicine